Hinge Health Authorizes $250mln Share Repurchase Program
ByAinvest
Wednesday, Nov 12, 2025 2:36 pm ET1min read
HNGE--
Hinge Health's board of directors has approved a $250 million share repurchase program. The company generated $108 million in cash from operations and $118 million in free cash flow in the first three quarters of 2025, with a robust balance sheet of nearly $500 million in cash and investments. The repurchase program will allow the company to repurchase shares to strengthen its capital structure.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet